Compare Suven Life Sciences with Biocon - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

SUVEN LIFE SCIENCES vs BIOCON - Comparison Results

BIOCON  
   Change

Biocon is India's largest biotechnology company with presence in biopharmaceuticals, custom research and clinical research. It started as an enzymes manufacturer and later evolved into an integrated biopharmaceutical company. The company has two subs... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    SUVEN LIFE SCIENCES BIOCON SUVEN LIFE SCIENCES/
BIOCON
 
P/E (TTM) x -81.7 33.0 - View Chart
P/BV x 1.3 3.9 32.6% View Chart
Dividend Yield % 1.8 0.3 715.9%  

Financials

 SUVEN LIFE SCIENCES   BIOCON
EQUITY SHARE DATA
    SUVEN LIFE SCIENCES
Mar-19
BIOCON
Mar-19
SUVEN LIFE SCIENCES/
BIOCON
5-Yr Chart
Click to enlarge
High Rs338707 47.7%   
Low Rs169554 30.6%   
Sales per share (Unadj.) Rs52.191.9 56.7%  
Earnings per share (Unadj.) Rs6.816.7 40.9%  
Cash flow per share (Unadj.) Rs8.624.2 35.5%  
Dividends per share (Unadj.) Rs1.501.00 150.0%  
Dividend yield (eoy) %0.60.2 373.0%  
Book value per share (Unadj.) Rs65.3101.6 64.2%  
Shares outstanding (eoy) m127.28600.00 21.2%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x4.96.9 70.9%   
Avg P/E ratio x37.137.7 98.4%  
P/CF ratio (eoy) x29.626.1 113.4%  
Price / Book Value ratio x3.96.2 62.6%  
Dividend payout %22.06.0 366.9%   
Avg Mkt Cap Rs m32,272378,330 8.5%   
No. of employees `0001.16.1 17.6%   
Total wages/salary Rs m66111,653 5.7%   
Avg. sales/employee Rs Th6,132.28,994.3 68.2%   
Avg. wages/employee Rs Th611.11,900.7 32.2%   
Avg. net profit/employee Rs Th803.51,635.3 49.1%   
INCOME DATA
Net Sales Rs m6,63555,144 12.0%  
Other income Rs m2421,444 16.8%   
Total revenues Rs m6,87756,588 12.2%   
Gross profit Rs m1,60415,883 10.1%  
Depreciation Rs m2214,478 4.9%   
Interest Rs m38709 5.3%   
Profit before tax Rs m1,58712,140 13.1%   
Minority Interest Rs m09 0.0%   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m7182,123 33.8%   
Profit after tax Rs m86910,026 8.7%  
Gross profit margin %24.228.8 83.9%  
Effective tax rate %45.217.5 258.6%   
Net profit margin %13.118.2 72.1%  
BALANCE SHEET DATA
Current assets Rs m6,23248,228 12.9%   
Current liabilities Rs m1,49030,376 4.9%   
Net working cap to sales %71.532.4 220.8%  
Current ratio x4.21.6 263.4%  
Inventory Days Days8668 126.6%  
Debtors Days Days8386 96.6%  
Net fixed assets Rs m4,04364,130 6.3%   
Share capital Rs m1273,000 4.2%   
"Free" reserves Rs m8,18357,980 14.1%   
Net worth Rs m8,31060,980 13.6%   
Long term debt Rs m1815,766 0.1%   
Total assets Rs m10,389121,924 8.5%  
Interest coverage x43.118.1 237.9%   
Debt to equity ratio x00.3 0.8%  
Sales to assets ratio x0.60.5 141.2%   
Return on assets %8.78.8 99.2%  
Return on equity %10.516.4 63.6%  
Return on capital %19.516.8 116.5%  
Exports to sales %028.1 0.0%   
Imports to sales %018.9 0.0%   
Exports (fob) Rs mNA15,506 0.0%   
Imports (cif) Rs mNA10,399 0.0%   
Fx inflow Rs m5,62215,506 36.3%   
Fx outflow Rs m1,79910,399 17.3%   
Net fx Rs m3,8225,107 74.8%   
CASH FLOW
From Operations Rs m35611,546 3.1%  
From Investments Rs m-279-7,138 3.9%  
From Financial Activity Rs m-225-2,417 9.3%  
Net Cashflow Rs m-1482,103 -7.0%  

Share Holding

Indian Promoters % 63.4 40.4 156.9%  
Foreign collaborators % 0.0 20.6 -  
Indian inst/Mut Fund % 0.0 8.4 -  
FIIs % 0.0 10.7 -  
ADR/GDR % 0.0 0.0 -  
Free float % 36.5 19.9 183.4%  
Shareholders   37,287 109,995 33.9%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare SUVEN LIFE SCIENCES With:   CIPLA  PIRAMAL ENTERPRISES  NATCO PHARMA  SHASUN PHARMA  PFIZER  

Compare SUVEN LIFE SCIENCES With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Ends 598 Points Lower, Nifty Settles Below 15,100-Mark; HDFC and JSW Steel Top Losers(Closing)

Indian share markets witnessed huge selling during closing hours today and ended their day deep in the red.

Related Views on News

BIOCON Announces Quarterly Results (3QFY21); Net Profit Down 19.7% (Quarterly Result Update)

Jan 25, 2021 | Updated on Jan 25, 2021

For the quarter ended December 2020, BIOCON has posted a net profit of Rs 2 bn (down 19.7% YoY). Sales on the other hand came in at Rs 19 bn (up 5.9% YoY). Read on for a complete analysis of BIOCON 's quarterly results.

BIOCON Announces Quarterly Results (2QFY21); Net Profit Down 23.9% (Quarterly Result Update)

Oct 29, 2020 | Updated on Oct 29, 2020

For the quarter ended September 2020, BIOCON has posted a net profit of Rs 2 bn (down 23.9% YoY). Sales on the other hand came in at Rs 17 bn (up 11.0% YoY). Read on for a complete analysis of BIOCON 's quarterly results.

BIOCON Announces Quarterly Results (3QFY20); Net Profit Up 1.2% (Quarterly Result Update)

Jan 24, 2020 | Updated on Jan 24, 2020

For the quarter ended December 2019, BIOCON has posted a net profit of Rs 2 bn (up 1.2% YoY). Sales on the other hand came in at Rs 17 bn (up 13.5% YoY). Read on for a complete analysis of BIOCON 's quarterly results.

BIOCON Announces Quarterly Results (2QFY20); Net Profit Down 30.5% (Quarterly Result Update)

Nov 1, 2019 | Updated on Nov 1, 2019

For the quarter ended September 2019, BIOCON has posted a net profit of Rs 3 bn (down 30.5% YoY). Sales on the other hand came in at Rs 16 bn (up 19.0% YoY). Read on for a complete analysis of BIOCON 's quarterly results.

SUVEN LIFESCIENCES Announces Quarterly Results (1QFY20); Net Profit Up 47.2% (Quarterly Result Update)

Aug 28, 2019 | Updated on Aug 28, 2019

For the quarter ended June 2019, SUVEN LIFESCIENCES has posted a net profit of Rs 572 m (up 47.2% YoY). Sales on the other hand came in at Rs 2 bn (up 3.8% YoY). Read on for a complete analysis of SUVEN LIFESCIENCES's quarterly results.

More Views on News

Most Popular

It's the Beginning of a New Bull Phase in Smallcaps(Profit Hunter)

Feb 24, 2021

Last time the smallcap index crossed 19k a big correction followed. Here's what makes it different this time.

Make Rs 5,000 Per Day Trading the Market(Fast Profits Daily)

Feb 25, 2021

In this video, I'll show you how to get started on the path to daily trading profits.

I Believe the Investment of the Year Will Be...

Feb 19, 2021

In this episode, ace trader Brijesh Bhatia talks to us about the best investments of 2021, his profitable trading system, and much more.

The Hidden Tesla in My Great Indian Wealth Project(Profit Hunter)

Feb 23, 2021

An Indian company founded three decades ago in a garage caught my attention...

More

India's #1 Trader
Reveals His Secrets

Secret To Increasing Your Trading Profits Today
Get this Special Report,
The Secret to Increasing Your Trading Profits Today, Now!
We will never sell or rent your email id.
Please read our Terms

SUVEN LIFE SCIENCES SHARE PRICE


Mar 4, 2021 (Close)

TRACK SUVEN LIFE SCIENCES

  • Track your investment in SUVEN LIFE SCIENCES with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON SUVEN LIFE SCIENCES

SUVEN LIFE SCIENCES 5-YR ANALYSIS

COMPARE SUVEN LIFE SCIENCES WITH

MARKET STATS